Literature DB >> 17582160

Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study.

Toshiharu Ninomiya1, Michiaki Kubo, Yasufumi Doi, Koji Yonemoto, Yumihiro Tanizaki, Kazuhiko Tsuruya, Katsuo Sueishi, Masazumi Tsuneyoshi, Mitsuo Iida, Yutaka Kiyohara.   

Abstract

Information regarding the association between prehypertension BP level and renal arteriosclerosis is limited. In 652 consecutive population-based autopsy samples without hypertension treatment before death, the relationship between the severity of renal arteriosclerosis and BP levels classified according to the criteria of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure was examined. The age- and gender-adjusted frequencies of renal arteriosclerosis linearly increased with elevating BP levels; both hypertensive and prehypertensive subjects had significantly higher frequencies of renal arteriosclerosis than subjects with normal BP (normal 11.9%; prehypertension 28.5%; stage 1 hypertension 32.9%; stage 2 hypertension 58.2%; all P < 0.01 versus normal). In a logistic regression model, prehypertension was significantly associated with renal arteriosclerosis after adjustment for other cardiovascular risk factors (prehypertension multivariate-adjusted odds ratio [mOR] 5.99 [95% confidence interval (CI) 2.20 to 15.97]; stage 1 hypertension mOR 6.99 [95% CI 2.61 to 18.72]; stage 2 hypertension mOR 22.21 [95% CI 8.35 to 59.08]). This significant association was observed for all renal arterial sizes. The similar association was also observed for arteriolar hyalinosis. When the subjects were divided into those with and those without target organ damage, the impact of prehypertension on renal arteriosclerosis was similar for both groups (subjects without target organ damage mOR 5.04 [95% CI 1.36 to 18.62]; subjects with target organ damage mOR 6.42 [95% CI 1.29 to 32.04]). These findings suggest that both hypertension and prehypertension are associated significantly with the severity of renal arteriosclerosis, regardless of the presence or absence of target organ damage.

Entities:  

Mesh:

Year:  2007        PMID: 17582160     DOI: 10.1681/ASN.2007010067

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  11 in total

1.  Increased nocturnal blood pressure variability is associated with renal arteriolar hyalinosis in normotensive patients with IgA nephropathy.

Authors:  Shinsuke Isobe; Naro Ohashi; Sayaka Ishigaki; Naoko Tsuji; Takayuki Tsuji; Akihiko Kato; Hideo Yasuda
Journal:  Hypertens Res       Date:  2017-07-13       Impact factor: 3.872

2.  Detection and Clinical Patterns of Nephron Hypertrophy and Nephrosclerosis Among Apparently Healthy Adults.

Authors:  Aleksandar Denic; Mariam P Alexander; Vidhu Kaushik; Lilach O Lerman; John C Lieske; Mark D Stegall; Joseph J Larson; Walter K Kremers; Terri J Vrtiska; Harini A Chakkera; Emilio D Poggio; Andrew D Rule
Journal:  Am J Kidney Dis       Date:  2016-02-06       Impact factor: 8.860

3.  Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution.

Authors:  Martin Bitzan; Jodie D Ouahed; Preetha Krishnamoorthy; Chantal Bernard
Journal:  Pediatr Nephrol       Date:  2008-03-20       Impact factor: 3.714

Review 4.  Treating prehypertension: a review of the evidence.

Authors:  Norman M Kaplan
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

5.  BP Reduction, Kidney Function Decline, and Cardiovascular Events in Patients without CKD.

Authors:  Rita Magriço; Miguel Bigotte Vieira; Catarina Viegas Dias; Lia Leitão; João Sérgio Neves
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-03       Impact factor: 8.237

6.  Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study.

Authors:  Kenji Maki; Jun Hata; Satoko Sakata; Emi Oishi; Yoshihiko Furuta; Toshiaki Nakano; Yoshinao Oda; Takanari Kitazono; Toshiharu Ninomiya
Journal:  Am J Nephrol       Date:  2022-02-01       Impact factor: 3.754

7.  Prevalence, risk factors, and management of prehypertension.

Authors:  Wenwen Zhang; Ninghua Li
Journal:  Int J Hypertens       Date:  2011-10-29       Impact factor: 2.420

Review 8.  Arteriosclerosis, atherosclerosis, arteriolosclerosis, and Monckeberg medial calcific sclerosis: what is the difference?

Authors:  Vanessa Prado Dos Santos; Geanete Pozzan; Valter Castelli; Roberto Augusto Caffaro
Journal:  J Vasc Bras       Date:  2021-06-25

9.  Prehypertension and Chronic Kidney Disease in Chinese Population: Four-Year Follow-Up Study.

Authors:  Hao Xue; Jianli Wang; Jinhong Hou; Junjuan Li; Jingsheng Gao; Shuohua Chen; Hang Zhu; Shouling Wu
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

10.  Age-Related Renal Microvascular Changes: Evaluation by Three-Dimensional Digital Imaging of the Human Renal Microcirculation Using Virtual Microscopy.

Authors:  Noriko Uesugi; Yoshihito Shimazu; Kazunori Kikuchi; Michio Nagata
Journal:  Int J Mol Sci       Date:  2016-11-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.